<?xml version="1.0" encoding="UTF-8"?>
<ref id="B35-pharmaceuticals-14-00002">
 <label>35.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lee</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Herrmann</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Deng</surname>
    <given-names>J.-H.</given-names>
   </name>
   <name>
    <surname>Kujawski</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Niu</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Forman</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Jove</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Pardoll</surname>
    <given-names>D.M.</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>Persistently Activated Stat3 Maintains Constitutive NF-ÎºB Activity in Tumors</article-title>
  <source>Cancer Cell</source>
  <year>2009</year>
  <volume>15</volume>
  <fpage>283</fpage>
  <lpage>293</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ccr.2009.02.015</pub-id>
  <pub-id pub-id-type="pmid">19345327</pub-id>
 </element-citation>
</ref>
